Anterior cervical discectomy and fusion (ACDF) is one of the most frequently performed spine procedures for different indications in the cervical spine. Various postoperative complications have been reported following the ACDF. This systematic review and meta-analysis aimed to calculate the incidence rate of different postoperative complications associated with ACDF surgery and also identify underlying risk factors for each complication. A systematic review of the literature was performed in PubMed/MEDLINE, Embase, and the Cochrane Library for observational studies published between January 1996 and March 2023 and reporting postoperative complications associated with ACDF. Randomized controlled trials and interventional investigations were not included in this study. Meta-regression was also performed using generalized linear mixed models with a binomial probability distribution on various potential predicting factors. A total of 222 studies reporting the rate of complications associated with ACDF in 50,584 patients were included in the present study. The overall postoperative complication rate was 16%. The most common complications were excessive neck swelling (11.3%), pseudarthrosis (10.0%), dysphagia (9.5%), cage/graft subsidence (9.4%), worsening myelopathy (7.7%), and hoarseness (2.3%). The rate of nonhome discharge, readmission, and mortality were 13.8%, 3.7%, and 0.1% respectively. Based on meta-regression, more levels of fusion and increased age were significantly associated with an increase in the pooled overall postoperative complication rate. Moreover, the rate of some postoperative complications was significantly associated with a number of perioperative characteristics. To our knowledge, this study has been the most extensive meta-analysis conducted on the existing literature regarding ACDF-related complications and potential risk factors. However, future high-quality prospective studies or clinical trials are highly required to provide further evidence and also validate the present findings.
Pressure ulcers are one of the leading complications in bedridden patients that result in multiple burdens on healthcare systems and patients (11 billion dollars/year). The prevalence of pressure ulcers in traumatic brain injury patients is 1.5‐fold compared with the other bedridden patients. Moreover, critical traumatic brain injury patients who are admitted to the intensive care unit experience severe pressure ulcers and further complications. The motor/sensory disabilities and low supplementation and oxygenation to the pressured side were the main mechanisms of the typical pressure ulcers. Intellectual evaluation is the first essential step to prevent the development of pressure ulcers in high‐risk patients. Till now, different scales, including Injury Scale Score and Braden Scale Score, have been provided to assess the pressure ulcer. Since low stages of pressure ulcers heal rapidly, traumatic brain injury patients require a periodical assessment to prevent further developments timely. Alongside different procedures provided to prevent and treat any pressure ulcer, traumatic brain injury patients required additional specific protections. For the first line, fast and efficient rehabilitation repairs motor/sensory disabilities and decreases the chance of pressure ulcer. Our review indicated that pressure ulcer in traumatic brain injury had several complex mechanisms that demand special care. Therefore, further studies are required to address these mechanisms and prevent their progression to typical and atypical pressure ulcers.
» Traditional reliance on preoperative glycated hemoglobin (HbA1c) for surgical eligibility and periprosthetic joint infection (PJI) risk stratification has significant limitations, including surgical delays and poor reflection of short-term metabolic instability. » Perioperative hyperglycemia and glucose variability are stronger and more consistent determinants of PJI risk than static glycemic indices such as HbA1c. » Novel markers, such as fructosamine, and technologies, including continuous glucose monitoring, provide improved assessment of short-term glycemic control and variability and demonstrate superior prognostic utility for PJI compared with HbA1c. » Antidiabetic therapies may differentially influence PJI risk: insulin dependence marks higher risk, whereas oral agents, particularly metformin and glucagon-like peptide-1 receptor agonists, are increasingly associated with reduced short-term PJI risk, especially among diabetic and morbidly obese patients undergoing hip and knee arthroplasty. » Mechanistic evidence implicates effects on inflammation, angiogenesis, immune function, and bacterial biofilm formation in mediating the relationship between glycemic control, antidiabetic therapies, and PJI risk.